Blood Test to Detect Breast Cancer

Options
gsr72
gsr72 Member Posts: 22
edited June 2014 in High Risk for Breast Cancer

Power3 Medical Products, Inc. Launches BC-SeraPro, the First Proteomics-Based Blood Serum Diagnostic Test for Breast Cancer

HOUSTON--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTC BB: PWRM - News), has signed its first distribution agreement to provide BC-SeraProTM, its breast cancer blood serum diagnostic test, in twelve Middle Eastern countries before the end of 2007. The agreement with Financial Advisory House's Medical Equipment Suppliers division (FAH), a Bahrain-based medical instrument distribution company, allows for the marketing and distribution of the BC-SeraPro breast cancer diagnostic test in: Bahrain, Egypt, Iraq, Jordan, Kuwait, Lebanon, Saudi Arabia, Oman, Qatar, Syria, United Arab Emirates, and Yemen.

BC-SeraPro is the first proteomics-based blood serum diagnostic test to be used for the early screening and diagnosis of breast cancer. As part of the agreement, FAH will market and distribute the BC-SeraPro diagnostic test to clinics and physicians in these Middle Eastern countries, with the tests analyzed in Power3's Houston-based, CLIA (Clinical Laboratory Improvement Amendment) certified proteomic laboratory.

Full story - http://biz.yahoo.com/bw/071015/20071015005267.html?.v=1

· Share on FacebookShare on Twitter

Comments

Categories